A bridge not too far: Linking disciplines through molecular imaging probes

Journal of Nuclear Medicine

Volumn 51, Issue 8, 2010, Pages 1258-1268

  Valliant, John F ^a  

^a Centre for Probe Development and Commercialization   (Canada)

Author keywords

Breast cancer; Collaboration; New technologies; Probes

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 16ALPHA FLUOROESTRADIOL F 18; CADMIUM DERIVATIVE; CADMIUM ZINC TELLURIDE; CHELATING AGENT; CONTRAST MEDIUM; COPPER 64; FLUORESCENT DYE; FLUORINE 18; FLUORINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; INDIUM; INDIUM 111; IRON OXIDE; N3S TC 99M; NANOPARTICLE; PERTUZUMAB; QUINOLINE DERIVATIVE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SESTAMIBI; SINGLE AMINO ACID CHELATE QUINOLINE; STREPTAVIDIN; TECHNETIUM; TECHNETIUM 99M; TECHNETIUM COMPLEX; TRACER; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; DIAGNOSTIC AGENT;

ANGIOGENESIS; BIOTECHNOLOGY; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CAMERA; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG CLEARANCE; DRUG HALF LIFE; DRUG UPTAKE; GENETIC ENGINEERING; HEALTH CARE; HUMAN; HYBRID COMPUTER; INTRADUCTAL CARCINOMA; ISOTOPE LABELING; MAMMOGRAPHY; MEDICAL RESEARCH; MOLECULAR IMAGING; MOLECULAR PROBE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MEDICINE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGY; REVIEW; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANTIBODY SPECIFICITY; BREAST TUMOR; DRUG DESIGN; FEMALE; GENETICS; METHODOLOGY; MOLECULAR BIOLOGY; SCINTISCANNING;

BREAST NEOPLASMS; DRUG DESIGN; FEMALE; GAMMA CAMERAS; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; ORGAN SPECIFICITY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77956210909     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.068312     Document Type: Review

References (80)

1. Zhou M, Johnson N, Blanchard D, Bryn S, Nelson J. Real world applications of breast-specific gamma imaging, initial experience of a community breast center and its potential impact on clinical care. Am J Surg. 2008;195:631-635. (Pubitemid 351522204)
2. Gambhir SS, Berman DS, Ziffer J, et al. A novel high sensitivity rapid acquisition single photon cardiac imaging camera. J Nucl Med. 2009;50:635-643.
3. Spanu A, Cottu P, Manca A, Chessa F, Sanna D, Madeddu G. Scintimammography with dedicated breast camera in unifocal and multifocal/multicentric primary breast cancer detection: a comparative study with SPECT. Int J Oncol. 2007;31:369-377.
4. Bronwell GL, Sweet WH. Localization of brain tumors with positron emitters. Nucleonics. 1953;11:40-45.
5. Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114:89-98.
6. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137-138.
7. Tafra L. Positron emission mammography: a new breast imaging device. J Surg Oncol. 2008;97:372-373.
8. Weinmann AL, Hruska CB, O'Connor MK. Design of optimal collimation for dedicated molecular breast imaging systems. Med Phys. 2009;36:845-856.
9. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-236.
10. 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med. 2000;41:1973-1979.
11. Hruskaa CB, O'Connor MK. Quantification of lesion size, depth and uptake using a dual-head molecular breast imaging system. Med Phys. 2008;35:1365-1376.
12. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-5312. (Pubitemid 350232263)
13. Mankoff DA, Link JM, Linden HM, Sundararajan L, Krohn KA. Tumor receptor imaging. J Nucl Med. 2008;49(suppl 2):149S-163S.
14. Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2 - response to therapy, other indications and future directions. J Nucl Med. 2009;50:738-748.
15. 99mTc- NC100692. J Nucl Med. 2006;47:1434-1439.
16. 99mTc- labelled NC 100692. Clin Physiol Funct Imaging. 2008;28:235-239.
17. Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in diagnosis and management of patients with breast cancer: part 1 - overview, detection and staging. J Nucl Med. 2009;50:569-581.
18. 18F]-fluorothymidine for imaging of primary breast cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2004;31:720-724.
19. 3 expression in man. Clin Cancer Res. 2006;12:3942-3949.
20. Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumors. Eur Radiol. 2007;17:861-872.
21. Katzenellenbogen JA, Welch MJ, Dehdashti F. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer. Anticancer Res. 1997;17:1573-1576. (Pubitemid 27263124)
22. Bénard F, Turcotte E. Imaging in breast cancer: single photon computed tomography and positron-emission tomography. Breast Cancer Res. 2005;7:153-162.
23. Tsuchida T, Okazawa H, Mori T, et al. In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET: influence of menstrual cycle and endogenous estrogen level. Nucl Med Biol. 2007;34:205-210.
24. Dehdashti F, Mortimer JE, Trinkaus K, et al. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat. 2009;113:509-517.
25. Linden HM, Stekhova SA, Link JM, et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol. 2006;24:2793-2799.
26. Shokeen M, Anderson CJ. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc Chem Res. 2009;42:832-841.
27. Mamat C, Ramenda T, Wuest FR. Recent application of click chemistry for the synthesis of radiotracers for molecular imaging. Mini Rev Org Chem. 2009;6:21-34.
28. Elizarov AM. Microreactors for radiopharmaceutical synthesis. Lab Chip. 2009;9:1326-1333.
29. Schottelius M, Wester H-J. Molecular imaging targeting peptide receptors. Methods. 2009;48:161-177.
30. Dunphy MPS, Lewis JS. Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET. J Nucl Med. 2009;50 (suppl 1):106S-121S.
31. Manning HC, Lander A, McKinley E, Mutic NJ. Accelerating the development of novel molecular imaging probes: a role for high-throughput screening. J Nucl Med. 2008;49:1401-1404.
32. Wahlberg E, Lendel C, Helgstrand M, et al. Affibody in complex with a target protein: structure and coupled folding. Proc Natl Acad Sci USA. 2003;100:3185-3190.
33. 18F]FBEM-ZHER2:342-Affibody molecule: a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging. 2008;35:1008-1018.
34. Jennings LE, Long NJ. "Two is better than one": probes for dual modality molecular imaging. Chem Commun (Camb). 2009;24:3511-3524.
35. Cheon J, Lee J-H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res. 2008;41:1630-1640.
36. Cherry SR, Louie AY, Jacobs RE. The integration of positron emission tomography with magnetic resonance imaging. Proc IEEE. 2008;96:416-438.
37. Lee HY, Li Z, Chen K, et al. PET/MRI dual modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med. 2008;49:1371-1379.
38. Sun G, Hagooly A, Xu J, et al. Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. Biomacromolecules. 2008;9:1997-2006.
39. Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J Nucl Med. 2009;50:493-496.
40. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for lice cells, in vivo imaging and diagnostics. Science. 2005;307:538-544.
41. Bhushan KR, Misra P, Liu F, Mathur S, Lenkinski RE, Frangioni JV. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc. 2008;130:17648-17649.
42. Hynynen K. Macromolecular delivery across the blood-brain barrier. In: Belting M. Macromolecular Drug Delivery Methods and Protocols: Methods in Molecular Biology. Vol 480. Totowa, NJ: Humana Press; 2009:1-11.
43. Willmann JK, Cheng Z, Davis C, et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology. 2008;249:212-219.
44. 99mTc- labeled microbubbles [abstract]. J Nucl Med. 2009;50(suppl 2):149P.
45. Boerman OC, Oyen WJG. Multimodality probes: amphibian cars for molecular imaging. J Nucl Med. 2008;49:1213-1214.
46. Frangioni JV. New technologies for human cancer imaging. J Clin Oncol. 2008;26:4012-4021.
47. Raylman RR, Majewski S, Smith MF, et al. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Phys Med Biol. 2008;53:637-653.
48. Duarte GM, Cabello C, Torresan RZ, et al. Radioguided intraoperative margins evaluation (RIME): preliminary results of a new technique to aid breast cancer resection. Eur J Surg Oncol. 2007;33:1150-1157.
49. Allweis TM, Kaufman Z, Lelcuk S, et al. A prospective randomized, controlled, multicenter study of a real-time intraoperative probe for positive margin detection in breast conserving surgery. Am J Surg. 2008;196:483-489.
50. 123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. Mol Imaging Biol. 2008;10:19-23.
51. Strong VE, Humm J, Russo P, et al. A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes. Surg Endosc. 2008;22:386-391.
52. Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew Chem Int Ed Engl. 2002;41:2596-2599.
53. Tornoe CW, Christensen C, Meldal M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem. 2002;67:3057-3064.
54. I catalyzed 1,3-dipolar cycloaddition. Tetrahedron Lett. 2006;47:6681-6684.
55. Sirion U, Kim HJ, Lee JH, et al. efficient F-18 labeling method for PET study: huisgen 1,3-dipolar cycloaddition of bioactive substances and F-18 labeled compounds. Tetrahedron Lett. 2007;48:3953-3957. (Pubitemid 46702266)
56. Knör S, Modlinger A, Poethko T, Schottelius M, Wester H-J, Kessler H. Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds. Chemistry. 2007;13:6082-6090.
57. 18F]fluoroethylazide for positron emission tomography. Bioconjug Chem. 2007;18:989-993.
58. 18F]SFB). J Labelled Comp Radiopharm. 2009;52:327-330.
59. Mindt TL, Müller C, Stuker F, et al. A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor. Bioconjug Chem. 2009;20:1940-1949.
60. Mindt TL, Schweinsberg C, Brans L, et al. A click approach to structurally diverse conjugates containing a central di-1,2,3-triazole metal chelate. Chem Med Chem. 2009;4:529-539.
61. 18F-labeled folic acid derivative. Bioconjug Chem. 2008;19:2462-2470.
62. Struthers H, Spingler B, Mindt TL, Schibli R. Click-to-chelate: design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest. Chemistry. 2008;14:6173-6183.
63. 99mTc complexes for correlating fluorescence and radioimaging studies. J Am Chem Soc. 2004;126:8598-8599.
64. Stephenson KA, Reid LC, Zubieta J, et al. Synthesis and screening of a library of Re/Tc-based amyloid probes derived from β-breaker peptides. Bioconjug Chem. 2008;19:1087-1094.
65. Schaffer P, Gleave JA, Lemon JA, et al. Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplants. Nucl Med Biol. 2008;35:159-169.
66. 6-specific peptide. Mol Imaging. 2009;8:111-121.
67. Parrott MC, Benhabbour SR, Saab C, et al. Synthesis, radiolabeling and bio-imaging of high generation polyester dendrimers. J Am Chem Soc. 2009;131:2906-2916.
68. Almutairi A, Rossin R, Shokeen M, et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA. 2009;106:685-690.
69. 123I]MIBG. J Labelled Comp Radiopharm. 1999;42:653-661.
70. Donovan A, Forbes J, Dorff P, Schaffer P, Babich J, Valliant JF. A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports. J Am Chem Soc. 2006;128:3536-3537.
71. McIntee JW, Sundararajan C, Donovan AC, Kovacs MS, Capretta A, Valliant JF. A convenient method for the preparation of fluorous tin derivatives for the fluorous labeling strategy. J Org Chem. 2008;73:8236-8243.
72. Donovan AC, Valliant JF. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity. Nucl Med Biol. 2008;35:741-746.
73. 18F]fluoride ion: nucleophilic fluorination as the detagging process. Angew Chem Int Ed Engl. 2009;48:586-589.
74. 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119:2333-2342.
75. 201Tl. J Nucl Med. 2004;45:1950-1959.
76. 64Cu(DO3A- xy-TPEP) as a potential radiotracer for monitoring tumor multidrug resistance. Bioconjug Chem. 2009;20:790-798.
77. Plössl K, Chandra R, Qu W, et al. A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl Med Biol. 2008;35:83-90. (Pubitemid 350298244)
78. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging. 2008;3:67-77.
79. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR. 2008;191:1805-1815.
80. Hruska CB, Boughey JC, Phillips SW, et al. Scientific Impact Recognition Award: molecular breast imaging: a review of the Mayo Clinic experience. Am J Surg. 2008;196:470-476.